{"id":363260,"date":"2025-08-31T09:52:43","date_gmt":"2025-08-31T09:52:43","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-zai-lab-limited\/"},"modified":"2025-08-31T09:52:43","modified_gmt":"2025-08-31T09:52:43","slug":"how-to-buy-zai-lab-limited","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-zai-lab-limited\/","title":{"rendered":"Zai Lab Limited (ZLAB) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Zai Lab Limited (ZLAB) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334018,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-363260","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Zai Lab Limited (ZLAB) Hisseleri Nas\u0131l Al\u0131n\u0131r - Zai Lab Limited (ZLAB) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Zai Lab Limited (ZLAB) Hisseleri Nas\u0131l Al\u0131n\u0131r - Zai Lab Limited (ZLAB) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Zai Lab Limited (ZLAB) hisse senedine yat\u0131r\u0131m yapmay\u0131, g\u00fcncel fiyat analizi, b\u00fcy\u00fcme tahminleri ve 2025 f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m yat\u0131r\u0131m stratejileri ile \u00f6\u011frenin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Zai Lab Limited (ZLAB) hisse senedine yat\u0131r\u0131m yapmay\u0131, g\u00fcncel fiyat analizi, b\u00fcy\u00fcme tahminleri ve 2025 f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m yat\u0131r\u0131m stratejileri ile \u00f6\u011frenin."},"intro":"\u0130leri biyoteknolojiye yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Zai Lab Limited, onkoloji ve imm\u00fcnoloji tedavilerine odaklanan ila\u00e7 inovasyonunun heyecan verici s\u0131n\u0131r\u0131n\u0131 temsil ediyor. Bu \u00c7inli biyoteknoloji devi, bilimsel m\u00fckemmeliyeti ticari potansiyelle birle\u015ftirerek h\u0131zla b\u00fcy\u00fcyen Asya sa\u011fl\u0131k pazar\u0131na maruz kalmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in cazip bir f\u0131rsat sunuyor. Mevcut performanstan gelecekteki b\u00fcy\u00fcme tetikleyicilerine kadar her \u015feyi ke\u015ffedece\u011fiz.","intro_source":{"label":"Intro","type":"text","formatted_value":"\u0130leri biyoteknolojiye yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Zai Lab Limited, onkoloji ve imm\u00fcnoloji tedavilerine odaklanan ila\u00e7 inovasyonunun heyecan verici s\u0131n\u0131r\u0131n\u0131 temsil ediyor. Bu \u00c7inli biyoteknoloji devi, bilimsel m\u00fckemmeliyeti ticari potansiyelle birle\u015ftirerek h\u0131zla b\u00fcy\u00fcyen Asya sa\u011fl\u0131k pazar\u0131na maruz kalmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in cazip bir f\u0131rsat sunuyor. Mevcut performanstan gelecekteki b\u00fcy\u00fcme tetikleyicilerine kadar her \u015feyi ke\u015ffedece\u011fiz."},"body_html":"<h2>\ud83d\udcc8 Zai Lab Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2> <p>31 A\u011fustos 2025 itibar\u0131yla, Zai Lab Limited (ZLAB) NASDAQ borsas\u0131nda <strong>33,10 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Hisse senedi, son volatiliteye ra\u011fmen kayda de\u011fer bir diren\u00e7 g\u00f6sterdi ve \u00f6nemli yukar\u0131 potansiyelle g\u00fc\u00e7l\u00fc analist deste\u011fini koruyor.<\/p> <p><strong>Takviminize Not Edin: 11 Kas\u0131m 2025<\/strong>, ZLAB yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in bir sonraki kritik tarih. \u015eirket, 2025 3. \u00e7eyrek finansal sonu\u00e7lar\u0131n\u0131 a\u00e7\u0131klayacak ve ge\u00e7mi\u015f desenler bu tarihin \u00f6nemli fiyat hareketlerine yol a\u00e7abilece\u011fini g\u00f6steriyor.<\/p> <h3>Tarihsel Kazan\u00e7 Etkisi Analizi<\/h3> <p>Son kazan\u00e7 tepkilerine bakmak, Zai Lab Limited (ZLAB) hissesine yat\u0131r\u0131m zamanlamas\u0131 i\u00e7in de\u011ferli i\u00e7g\u00f6r\u00fcler sa\u011flar:<\/p> <table> <thead> <tr> <th>Tarih<\/th> <th>Olay<\/th> <th>Haber \u00d6ncesi Fiyat<\/th> <th>Haber Sonras\u0131 De\u011fi\u015fim<\/th> <th>Analiz<\/th> <\/tr> <\/thead> <tbody> <tr> <td>7 A\u011fu 2025<\/td> <td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td> <td>36,82 $<\/td> <td>Karma tepki<\/td> <td>EPS tahminlerini kar\u015f\u0131lad\u0131 (-0,37 $) ancak gelir hedeflerini ka\u00e7\u0131rd\u0131<\/td> <\/tr> <tr> <td>8 May 2025<\/td> <td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td> <td>34,50 $<\/td> <td>%5,2 art\u0131\u015f (1 hafta)<\/td> <td>2024 4. \u00e7eyrek kay\u0131plar\u0131ndan (-0,80 $ EPS) iyile\u015fme<\/td> <\/tr> <tr> <td>27 \u015eub 2025<\/td> <td>2024 4. \u00c7eyrek<\/td> <td>32,10 $<\/td> <td>%8,7 art\u0131\u015f (3 g\u00fcn)<\/td> <td>\u00d6nemli maliyet azaltma ilerlemesi g\u00f6sterdi<\/td> <\/tr> <tr> <td>5 Kas 2024<\/td> <td>\u00dcr\u00fcn G\u00fcncellemesi<\/td> <td>30,80 $<\/td> <td>%4,1 art\u0131\u015f<\/td> <td>Olumlu \u00fcr\u00fcn hatt\u0131 geli\u015fme haberleri<\/td> <\/tr> <tr> <td>9 A\u011fu 2024<\/td> <td>2024 2. \u00c7eyrek<\/td> <td>29,40 $<\/td> <td>%3,2 d\u00fc\u015f\u00fc\u015f<\/td> <td>Gelir beklentilerini hafif\u00e7e ka\u00e7\u0131rd\u0131<\/td> <\/tr> <tr> <td>15 May 2024<\/td> <td>Klinik Veri<\/td> <td>28,10 $<\/td> <td>%6,8 art\u0131\u015f<\/td> <td>G\u00fc\u00e7l\u00fc onkoloji deneme sonu\u00e7lar\u0131<\/td> <\/tr> <\/tbody> <\/table> <p><strong>Desen \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: ZLAB genellikle kazan\u00e7 s\u00fcrprizlerine g\u00fc\u00e7l\u00fc tepki verir, olumlu klinik veriler en b\u00fcy\u00fck kazan\u00e7lar\u0131 tetikler. Son 2. \u00e7eyrek 2025 sonu\u00e7lar\u0131, gelirler d\u00fc\u015f\u00fck olsa bile \u015firketin kazan\u00e7 beklentilerini kar\u015f\u0131layabildi\u011fini ve finansal disiplini g\u00f6sterdi\u011fini ortaya koydu.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu ve Trend Analizi<\/h2> <p>Zai Lab hisseleri \u00f6nemli volatilite ya\u015fad\u0131 ancak son alt\u0131 ayda genel olarak pozitif bir seyir izledi:<\/p> <p><strong>\u015eubat 2025<\/strong>: 31,20 $ - Tatil sonras\u0131 konsolidasyon d\u00f6nemi<br\/> <strong>Mart 2025<\/strong>: 35,80 $ - Olumlu klinik deneme verileriyle %14,7 art\u0131\u015f<br\/> <strong>Nisan 2025<\/strong>: 33,50 $ - Geni\u015f biyoteknoloji sat\u0131\u015flar\u0131 aras\u0131nda %6,4 d\u00fczeltme<br\/> <strong>May\u0131s 2025<\/strong>: 37,20 $ | 1. \u00e7eyrek kazan\u00e7lar\u0131n\u0131n \u00fczerinde %11,0 toparlanma<br\/> <strong>Haziran 2025<\/strong>: 34,10 $ | Kar al\u0131mlar\u0131yla %8,3 d\u00fc\u015f\u00fc\u015f<br\/> <strong>Temmuz 2025<\/strong>: 32,80 $ | %3,8 devam eden konsolidasyon<br\/> <strong>A\u011fustos 2025<\/strong>: 33,10 $ | 2. \u00e7eyrek kazan\u00e7lar\u0131 \u00f6ncesi %0,9 stabilizasyon<\/p> <p>Hisse senedi, <strong>1,03 beta<\/strong> de\u011feri ile genel piyasa ile yakla\u015f\u0131k paralel hareket eder ancak biyoteknoloji hisselerine \u00f6zg\u00fc biraz daha y\u00fcksek volatilite g\u00f6sterir. 52 haftal\u0131k aral\u0131k 18,91 $ ile 44,34 $ aras\u0131nda olup, olumlu tetikleyiciler s\u0131ras\u0131nda \u00f6nemli yukar\u0131 potansiyel sunar.<\/p> <h3>Teknik Analiz Perspektifi<\/h3> <p>Y\u0131ll\u0131k aral\u0131\u011f\u0131n\u0131n ortalar\u0131na yak\u0131n i\u015flem g\u00f6ren ZLAB, birka\u00e7 cesaret verici teknik sinyal g\u00f6steriyor:<\/p> <ul> <li><strong>Destek Seviyesi<\/strong>: 30,00 $ civar\u0131nda g\u00fc\u00e7l\u00fc destek<\/li> <li><strong>Diren\u00e7<\/strong>: 36,00-37,00 $ aral\u0131\u011f\u0131nda \u00f6nemli diren\u00e7<\/li> <li><strong>Hareketli Ortalamalar<\/strong>: 200 g\u00fcnl\u00fck HO'nun (31,82 $) \u00fczerinde, 50 g\u00fcnl\u00fck HO'nun (36,12 $) alt\u0131nda i\u015flem g\u00f6r\u00fcyor<\/li> <li><strong>RSI<\/strong>: 63,03 seviyesinde, a\u015f\u0131r\u0131 al\u0131m b\u00f6lgesine yakla\u015fmakta ancak hen\u00fcz ula\u015fmad\u0131<\/li> <\/ul> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p>Kapsaml\u0131 analist projeksiyonlar\u0131 ve \u015firket temellerine dayanarak, Zai Lab Limited (ZLAB) hissesi i\u00e7in beklenenler \u015funlard\u0131r:<\/p> <ul> <li><strong>2025 Y\u0131l Sonu Hedefi<\/strong>: 34-36 $ aral\u0131\u011f\u0131   <ul>   <li><strong>Gerek\u00e7e<\/strong>: 4. \u00e7eyrek k\u00e2rl\u0131l\u0131\u011f\u0131na do\u011fru devam eden ilerleme, \u00fcr\u00fcn hatt\u0131 geli\u015fmeleri<\/li>   <li><strong>Karar<\/strong>: D\u00dc\u015e\u00dcK SATIN ALMA, d\u00fc\u015f\u00fc\u015flerde birikim<\/li>   <\/ul> <\/li> <li><strong>2026 Projeksiyonu<\/strong>: 48-52 $ aral\u0131\u011f\u0131 (mevcut seviyeden %45-57 art\u0131\u015f)   <ul>   <li><strong>Tetikleyiciler<\/strong>: Olas\u0131 d\u00fczenleyici onaylar, geni\u015fletilmi\u015f ticarile\u015ftirme<\/li>   <li><strong>G\u00f6r\u00fcn\u00fcm<\/strong>: SABIRLI YATIRIMCILAR \u0130\u00c7\u0130N G\u00dc\u00c7L\u00dc ALIM<\/li>   <\/ul> <\/li> <li><strong>2028 Tahmini<\/strong>: 55-60 $ aral\u0131\u011f\u0131 (%66-81 yukar\u0131 potansiyel)   <ul>   <li><strong>\u0130tici G\u00fc\u00e7ler<\/strong>: Tam \u00fcr\u00fcn hatt\u0131 gelirle\u015ftirme, pazar geni\u015flemesi<\/li>   <li><strong>Potansiyel<\/strong>: D\u00f6n\u00fc\u015ft\u00fcr\u00fcc\u00fc b\u00fcy\u00fcme a\u015famas\u0131<\/li>   <\/ul> <\/li> <li><strong>2030 Vizyonu<\/strong>: 65-75 $ aral\u0131\u011f\u0131 (%96-126 getiri)   <ul>   <li><strong>Temel<\/strong>: Kurulu ticari platform, \u00e7e\u015fitlendirilmi\u015f gelir<\/li>   <li><strong>Uzun Vadeli<\/strong>: M\u00dcKEMMEL bile\u015fik getiri f\u0131rsat\u0131<\/li>   <\/ul> <\/li> <\/ul> <p><strong>Genel Tavsiye<\/strong>: Biyoteknoloji volatilitesi nedeniyle dolar-maliyet ortalamas\u0131 stratejisi ile uzun vadeli b\u00fcy\u00fcme i\u00e7in ALIM.<\/p> <h2>\u26a0\ufe0f Yat\u0131r\u0131m Riskleri ve Olumlu Sinyaller<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Temel Riskler<\/h3> <ul> <li><strong>Klinik Deneme Ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong>: Bir biyoteknoloji \u015firketi olarak, ZLAB klinik deneme aksakl\u0131klar\u0131 riski ta\u015f\u0131r ve bu durum de\u011ferlemeyi \u00f6nemli \u00f6l\u00e7\u00fcde etkileyebilir. \u0130la\u00e7 geli\u015ftirme end\u00fcstrisinde ba\u015far\u0131s\u0131zl\u0131k oran\u0131 y\u00fcksektir.<\/li> <li><strong>D\u00fczenleyici Engeller<\/strong>: \u00c7in ve uluslararas\u0131 d\u00fczenleyici onaylar s\u00fcrekli zorluklar sunar. FDA veya NMPA gibi kurumlar\u0131n gecikmeleri veya reddi ticarile\u015ftirme takvimlerini aksatabilir.<\/li> <li><strong>Mali S\u00fcrd\u00fcr\u00fclebilirlik<\/strong>: K\u00e2rl\u0131l\u0131\u011fa do\u011fru ilerleme kaydedilse de, \u015firket h\u00e2l\u00e2 zarar etmektedir (-212,52 milyon $ TTM). Ar-Ge i\u00e7in devam eden sermaye gereksinimleri finansal bask\u0131 yaratabilir.<\/li> <li><strong>Rekabet Bask\u0131s\u0131<\/strong>: Onkoloji ve imm\u00fcnoloji alanlar\u0131 giderek rekabet\u00e7i hale gelmekte, b\u00fcy\u00fck ila\u00e7 \u015firketleri benzer tedaviler geli\u015ftirmektedir.<\/li> <li><strong>D\u00f6viz ve Jeopolitik Riskler<\/strong>: \u00c7in merkezli ve k\u00fcresel hedefleri olan ZLAB, d\u00f6viz dalgalanmalar\u0131 ve uluslararas\u0131 geni\u015flemeyi etkileyebilecek jeopolitik gerilimlerle kar\u015f\u0131 kar\u015f\u0131yad\u0131r.<\/li> <\/ul> <h3>2025 Yat\u0131r\u0131m\u0131 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>K\u00e2rl\u0131l\u0131\u011fa Giden Yol<\/strong>: \u015eirket, 2025 4. \u00e7eyrekte GAAP d\u0131\u015f\u0131 k\u00e2rl\u0131l\u0131\u011fa ula\u015fma yolunda olup, bu biyoteknoloji hisselerinde genellikle \u00f6nemli \u00e7arpan art\u0131\u015f\u0131n\u0131 tetikleyen kritik bir d\u00f6n\u00fcm noktas\u0131d\u0131r.<\/li> <li><strong>G\u00fc\u00e7l\u00fc Ticari Uygulama<\/strong>: VYVGART, ilk tam lansman y\u0131l\u0131nda 93,6 milyon $ gelir elde ederek sa\u011flam ticari yetenekler ve pazar kabul\u00fc g\u00f6sterdi.<\/li> <li><strong>\u00dcr\u00fcn Hatt\u0131 Tetikleyicileri<\/strong>: 2025 ikinci yar\u0131s\u0131nda ZL-1310 kay\u0131t denemesinin ba\u015flamas\u0131 ve bemarituzumab geli\u015fmeleri gibi bir\u00e7ok k\u0131sa vadeli tetikleyici \u00f6nemli yukar\u0131 potansiyel yarat\u0131yor.<\/li> <li><strong>Analist G\u00fcveni<\/strong>: 12 analistten 11'i al\u0131m tavsiyesi veriyor ve ortalama fiyat hedefi 56,31 $ ile %65+ yukar\u0131 potansiyel sunuyor.<\/li> <li><strong>Pazar Konumu<\/strong>: \u00c7in'in b\u00fcy\u00fcyen biyofarma pazar\u0131nda bask\u0131n konum ve k\u00fcresel geni\u015fleme yetenekleri \u00e7e\u015fitlendirilmi\u015f b\u00fcy\u00fcme f\u0131rsatlar\u0131 sa\u011fl\u0131yor.<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ul> <li><strong>Stratejik Birikim<\/strong>: K\u00fc\u00e7\u00fck pozisyon boyutlar\u0131yla ba\u015flay\u0131n ve giri\u015f zamanlamas\u0131 yerine dolar-maliyet ortalamas\u0131 ile maruziyeti kademeli olarak art\u0131r\u0131n.<\/li> <li><strong>Kazan\u00e7 Takvimi Fark\u0131ndal\u0131\u011f\u0131<\/strong>: 11 Kas\u0131m 2025 kazan\u00e7 a\u00e7\u0131klamas\u0131 i\u00e7in uyar\u0131lar kurun ve temel g\u00f6stergeler g\u00fc\u00e7l\u00fc kal\u0131rsa kazan\u00e7 sonras\u0131 zay\u0131fl\u0131klarda al\u0131m yapmay\u0131 d\u00fc\u015f\u00fcn\u00fcn.<\/li> <li><strong>Portf\u00f6y Da\u011f\u0131l\u0131m\u0131<\/strong>: Biyoteknoloji sekt\u00f6r\u00fc volatilitesi ve \u015firket \u00f6zel riskleri nedeniyle ZLAB maruziyetini toplam portf\u00f6y\u00fcn %5-10'u ile s\u0131n\u0131rlay\u0131n.<\/li> <li><strong>Uzun Vadeli Bak\u0131\u015f<\/strong>: Bu yat\u0131r\u0131m\u0131 k\u0131sa vadeli i\u015flem yerine 3-5 y\u0131ll\u0131k bir yat\u0131r\u0131m olarak g\u00f6r\u00fcn, b\u00f6ylece \u00fcr\u00fcn hatt\u0131 gelirle\u015ftirme potansiyelinin tamam\u0131n\u0131 yakalayabilirsiniz.<\/li> <li><strong>Esprili Ger\u00e7eklik Kontrol\u00fc<\/strong>: \"Biyoteknoloji hisseleriyle i\u015flem yapmak, bilimsel deneyleri izlemek gibidir - %90 beklemek, %9 endi\u015felenmek ve %1 t\u00fcm \u00e7abaya de\u011fen muhte\u015fem sonu\u00e7lar!\"<\/li> <\/ul> <h2>\u2705 Zai Lab Limited (ZLAB) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr> <th>Ad\u0131m<\/th> <th>\u0130\u015flem<\/th> <th>Neden \u00d6nemli<\/th> <\/tr> <\/thead> <tbody> <tr> <td>1<\/td> <td>Bir Ticaret Platformu Se\u00e7in<\/td> <td>NASDAQ eri\u015fimi ve rekabet\u00e7i komisyon oranlar\u0131 sunan bir arac\u0131 kurum se\u00e7in<\/td> <\/tr> <tr> <td>2<\/td> <td>Hesap Fonlamas\u0131n\u0131 Tamamlay\u0131n<\/td> <td>Biyoteknoloji volatilitesini g\u00f6z \u00f6n\u00fcnde bulundurarak riske atmaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td> <\/tr> <tr> <td>3<\/td> <td>\"ZLAB\" Aramas\u0131 Yap\u0131n<\/td> <td>Do\u011fru menkul k\u0131ymeti ald\u0131\u011f\u0131n\u0131zdan emin olmak i\u00e7in tam sembol\u00fc kullan\u0131n<\/td> <\/tr> <tr> <td>4<\/td> <td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td> <td>Piyasa emirleri yerine giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td> <\/tr> <tr> <td>5<\/td> <td>\u0130nceleyin ve Ger\u00e7ekle\u015ftirin<\/td> <td>Onaylamadan \u00f6nce miktar ve fiyat dahil olmak \u00fczere emir detaylar\u0131n\u0131 \u00e7ift kontrol edin<\/td> <\/tr> <\/tbody> <\/table> <p><strong>Profesyonel \u0130pucu<\/strong>: Arac\u0131n\u0131z sunuyorsa, tam olmayan paylar kullanmay\u0131 d\u00fc\u015f\u00fcn\u00fcn; b\u00f6ylece mevcut fiyatlarla tam hisse almak zorunda kalmadan pozisyonlar\u0131n\u0131z\u0131 kademeli olarak olu\u015fturabilirsiniz.<\/p> <h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Cazip?<\/h2> <p>Zai Lab Limited (ZLAB) hisse senedi ile yat\u0131r\u0131m yolculu\u011funa ba\u015flayanlar i\u00e7in Pocket Option, s\u00fcreci kolayla\u015ft\u0131ran birka\u00e7 avantaj sunar:<\/p> <ul> <li><strong>Eri\u015filebilirlik<\/strong>: Sadece 5 $ minimum depozito ile, \u00f6nemli sermaye taahh\u00fcd\u00fc olmadan pozisyon olu\u015fturmaya ba\u015flayabilirsiniz; ger\u00e7ek para ile stratejileri test etmek i\u00e7in m\u00fckemmeldir ancak risk s\u0131n\u0131rl\u0131d\u0131r.<\/li> <li><strong>H\u0131zl\u0131 \u0130\u015flem<\/strong>: Platformun 1 dakikal\u0131k KYC s\u00fcreci, tek bir kimlik belgesi kullanarak kay\u0131t sonras\u0131 hemen i\u015flem yapmaya ba\u015flaman\u0131z\u0131 sa\u011flar.<\/li> <li><strong>Esnek Para \u00c7ekme<\/strong>: Kripto paralar, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k se\u00e7enekleri dahil 100'den fazla para \u00e7ekme y\u00f6ntemi, uluslararas\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in kolayl\u0131k ve eri\u015filebilirlik sunar.<\/li> <li><strong>E\u011fitim Kaynaklar\u0131<\/strong>: <a href=\"https:\/\/pocketoption.com\/blog\">Pocket Option blogu<\/a>, yat\u0131r\u0131m kararlar\u0131n\u0131z\u0131 bilgilendirmek i\u00e7in de\u011ferli i\u00e7g\u00f6r\u00fcler ve piyasa analizleri sunar.<\/li> <\/ul> <h2>\ud83c\udf0d 2025'te Zai Lab: Biyoteknoloji \u0130novasyon Lideri<\/h2> <p>Zai Lab Limited, onkoloji, otoimm\u00fcn hastal\u0131klar, enfeksiyon hastal\u0131klar\u0131 ve sinirbilim alanlar\u0131nda yenilik\u00e7i tedaviler geli\u015ftirmeye ve ticarile\u015ftirmeye odaklanan \u00f6nde gelen bir biyofarmas\u00f6tik \u015firket olarak kendini kan\u0131tlad\u0131. \u015eirketin stratejik yakla\u015f\u0131m\u0131, dahili ila\u00e7 ke\u015ffi ile stratejik ortakl\u0131klar\u0131 birle\u015ftirerek \u00e7e\u015fitlendirilmi\u015f bir \u00fcr\u00fcn hatt\u0131 olu\u015fturuyor.<\/p> <p>\u015eirketin en geli\u015fmi\u015f varl\u0131\u011f\u0131 olan ZL-1310, DLL3 hedefli antikor-ila\u00e7 konjugat\u0131 olarak k\u00fc\u00e7\u00fck h\u00fccreli akci\u011fer kanseri tedavisinde potansiyel bir at\u0131l\u0131m\u0131 temsil ediyor. 2025 sonlar\u0131nda planlanan kay\u0131t denemesi ve 2027'ye kadar olas\u0131 h\u0131zland\u0131r\u0131lm\u0131\u015f onay ile bu program, bu zorlu kanser t\u00fcr\u00fc i\u00e7in tedavi manzaras\u0131n\u0131 d\u00f6n\u00fc\u015ft\u00fcrebilir.<\/p> <p><strong>2025 \u0130\u00e7in \u0130lgin\u00e7 Bir Ger\u00e7ek<\/strong>: Zai Lab, bu y\u0131l ara\u015ft\u0131rma ekibinin onkoloji i\u00e7in geli\u015ftirilen bir bile\u015fi\u011fin nadir n\u00f6rolojik hastal\u0131klar\u0131n tedavisinde beklenmedik etkinlik g\u00f6sterdi\u011fini ke\u015ffetmesiyle man\u015fetlere \u00e7\u0131kt\u0131; bu, tamamen yeni bir terap\u00f6tik uygulamaya yol a\u00e7t\u0131 ve ila\u00e7 ke\u015ffinin tesad\u00fcfi do\u011fas\u0131n\u0131 g\u00f6sterdi!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Zai Lab Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2>\n<p>31 A\u011fustos 2025 itibar\u0131yla, Zai Lab Limited (ZLAB) NASDAQ borsas\u0131nda <strong>33,10 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Hisse senedi, son volatiliteye ra\u011fmen kayda de\u011fer bir diren\u00e7 g\u00f6sterdi ve \u00f6nemli yukar\u0131 potansiyelle g\u00fc\u00e7l\u00fc analist deste\u011fini koruyor.<\/p>\n<p><strong>Takviminize Not Edin: 11 Kas\u0131m 2025<\/strong>, ZLAB yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in bir sonraki kritik tarih. \u015eirket, 2025 3. \u00e7eyrek finansal sonu\u00e7lar\u0131n\u0131 a\u00e7\u0131klayacak ve ge\u00e7mi\u015f desenler bu tarihin \u00f6nemli fiyat hareketlerine yol a\u00e7abilece\u011fini g\u00f6steriyor.<\/p>\n<h3>Tarihsel Kazan\u00e7 Etkisi Analizi<\/h3>\n<p>Son kazan\u00e7 tepkilerine bakmak, Zai Lab Limited (ZLAB) hissesine yat\u0131r\u0131m zamanlamas\u0131 i\u00e7in de\u011ferli i\u00e7g\u00f6r\u00fcler sa\u011flar:<\/p>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<th>Analiz<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>7 A\u011fu 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>36,82 $<\/td>\n<td>Karma tepki<\/td>\n<td>EPS tahminlerini kar\u015f\u0131lad\u0131 (-0,37 $) ancak gelir hedeflerini ka\u00e7\u0131rd\u0131<\/td>\n<\/tr>\n<tr>\n<td>8 May 2025<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>34,50 $<\/td>\n<td>%5,2 art\u0131\u015f (1 hafta)<\/td>\n<td>2024 4. \u00e7eyrek kay\u0131plar\u0131ndan (-0,80 $ EPS) iyile\u015fme<\/td>\n<\/tr>\n<tr>\n<td>27 \u015eub 2025<\/td>\n<td>2024 4. \u00c7eyrek<\/td>\n<td>32,10 $<\/td>\n<td>%8,7 art\u0131\u015f (3 g\u00fcn)<\/td>\n<td>\u00d6nemli maliyet azaltma ilerlemesi g\u00f6sterdi<\/td>\n<\/tr>\n<tr>\n<td>5 Kas 2024<\/td>\n<td>\u00dcr\u00fcn G\u00fcncellemesi<\/td>\n<td>30,80 $<\/td>\n<td>%4,1 art\u0131\u015f<\/td>\n<td>Olumlu \u00fcr\u00fcn hatt\u0131 geli\u015fme haberleri<\/td>\n<\/tr>\n<tr>\n<td>9 A\u011fu 2024<\/td>\n<td>2024 2. \u00c7eyrek<\/td>\n<td>29,40 $<\/td>\n<td>%3,2 d\u00fc\u015f\u00fc\u015f<\/td>\n<td>Gelir beklentilerini hafif\u00e7e ka\u00e7\u0131rd\u0131<\/td>\n<\/tr>\n<tr>\n<td>15 May 2024<\/td>\n<td>Klinik Veri<\/td>\n<td>28,10 $<\/td>\n<td>%6,8 art\u0131\u015f<\/td>\n<td>G\u00fc\u00e7l\u00fc onkoloji deneme sonu\u00e7lar\u0131<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Desen \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: ZLAB genellikle kazan\u00e7 s\u00fcrprizlerine g\u00fc\u00e7l\u00fc tepki verir, olumlu klinik veriler en b\u00fcy\u00fck kazan\u00e7lar\u0131 tetikler. Son 2. \u00e7eyrek 2025 sonu\u00e7lar\u0131, gelirler d\u00fc\u015f\u00fck olsa bile \u015firketin kazan\u00e7 beklentilerini kar\u015f\u0131layabildi\u011fini ve finansal disiplini g\u00f6sterdi\u011fini ortaya koydu.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu ve Trend Analizi<\/h2>\n<p>Zai Lab hisseleri \u00f6nemli volatilite ya\u015fad\u0131 ancak son alt\u0131 ayda genel olarak pozitif bir seyir izledi:<\/p>\n<p><strong>\u015eubat 2025<\/strong>: 31,20 $ &#8211; Tatil sonras\u0131 konsolidasyon d\u00f6nemi<br \/> <strong>Mart 2025<\/strong>: 35,80 $ &#8211; Olumlu klinik deneme verileriyle %14,7 art\u0131\u015f<br \/> <strong>Nisan 2025<\/strong>: 33,50 $ &#8211; Geni\u015f biyoteknoloji sat\u0131\u015flar\u0131 aras\u0131nda %6,4 d\u00fczeltme<br \/> <strong>May\u0131s 2025<\/strong>: 37,20 $ | 1. \u00e7eyrek kazan\u00e7lar\u0131n\u0131n \u00fczerinde %11,0 toparlanma<br \/> <strong>Haziran 2025<\/strong>: 34,10 $ | Kar al\u0131mlar\u0131yla %8,3 d\u00fc\u015f\u00fc\u015f<br \/> <strong>Temmuz 2025<\/strong>: 32,80 $ | %3,8 devam eden konsolidasyon<br \/> <strong>A\u011fustos 2025<\/strong>: 33,10 $ | 2. \u00e7eyrek kazan\u00e7lar\u0131 \u00f6ncesi %0,9 stabilizasyon<\/p>\n<p>Hisse senedi, <strong>1,03 beta<\/strong> de\u011feri ile genel piyasa ile yakla\u015f\u0131k paralel hareket eder ancak biyoteknoloji hisselerine \u00f6zg\u00fc biraz daha y\u00fcksek volatilite g\u00f6sterir. 52 haftal\u0131k aral\u0131k 18,91 $ ile 44,34 $ aras\u0131nda olup, olumlu tetikleyiciler s\u0131ras\u0131nda \u00f6nemli yukar\u0131 potansiyel sunar.<\/p>\n<h3>Teknik Analiz Perspektifi<\/h3>\n<p>Y\u0131ll\u0131k aral\u0131\u011f\u0131n\u0131n ortalar\u0131na yak\u0131n i\u015flem g\u00f6ren ZLAB, birka\u00e7 cesaret verici teknik sinyal g\u00f6steriyor:<\/p>\n<ul>\n<li><strong>Destek Seviyesi<\/strong>: 30,00 $ civar\u0131nda g\u00fc\u00e7l\u00fc destek<\/li>\n<li><strong>Diren\u00e7<\/strong>: 36,00-37,00 $ aral\u0131\u011f\u0131nda \u00f6nemli diren\u00e7<\/li>\n<li><strong>Hareketli Ortalamalar<\/strong>: 200 g\u00fcnl\u00fck HO&#8217;nun (31,82 $) \u00fczerinde, 50 g\u00fcnl\u00fck HO&#8217;nun (36,12 $) alt\u0131nda i\u015flem g\u00f6r\u00fcyor<\/li>\n<li><strong>RSI<\/strong>: 63,03 seviyesinde, a\u015f\u0131r\u0131 al\u0131m b\u00f6lgesine yakla\u015fmakta ancak hen\u00fcz ula\u015fmad\u0131<\/li>\n<\/ul>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p>Kapsaml\u0131 analist projeksiyonlar\u0131 ve \u015firket temellerine dayanarak, Zai Lab Limited (ZLAB) hissesi i\u00e7in beklenenler \u015funlard\u0131r:<\/p>\n<ul>\n<li><strong>2025 Y\u0131l Sonu Hedefi<\/strong>: 34-36 $ aral\u0131\u011f\u0131\n<ul>\n<li><strong>Gerek\u00e7e<\/strong>: 4. \u00e7eyrek k\u00e2rl\u0131l\u0131\u011f\u0131na do\u011fru devam eden ilerleme, \u00fcr\u00fcn hatt\u0131 geli\u015fmeleri<\/li>\n<li><strong>Karar<\/strong>: D\u00dc\u015e\u00dcK SATIN ALMA, d\u00fc\u015f\u00fc\u015flerde birikim<\/li>\n<\/ul>\n<\/li>\n<li><strong>2026 Projeksiyonu<\/strong>: 48-52 $ aral\u0131\u011f\u0131 (mevcut seviyeden %45-57 art\u0131\u015f)\n<ul>\n<li><strong>Tetikleyiciler<\/strong>: Olas\u0131 d\u00fczenleyici onaylar, geni\u015fletilmi\u015f ticarile\u015ftirme<\/li>\n<li><strong>G\u00f6r\u00fcn\u00fcm<\/strong>: SABIRLI YATIRIMCILAR \u0130\u00c7\u0130N G\u00dc\u00c7L\u00dc ALIM<\/li>\n<\/ul>\n<\/li>\n<li><strong>2028 Tahmini<\/strong>: 55-60 $ aral\u0131\u011f\u0131 (%66-81 yukar\u0131 potansiyel)\n<ul>\n<li><strong>\u0130tici G\u00fc\u00e7ler<\/strong>: Tam \u00fcr\u00fcn hatt\u0131 gelirle\u015ftirme, pazar geni\u015flemesi<\/li>\n<li><strong>Potansiyel<\/strong>: D\u00f6n\u00fc\u015ft\u00fcr\u00fcc\u00fc b\u00fcy\u00fcme a\u015famas\u0131<\/li>\n<\/ul>\n<\/li>\n<li><strong>2030 Vizyonu<\/strong>: 65-75 $ aral\u0131\u011f\u0131 (%96-126 getiri)\n<ul>\n<li><strong>Temel<\/strong>: Kurulu ticari platform, \u00e7e\u015fitlendirilmi\u015f gelir<\/li>\n<li><strong>Uzun Vadeli<\/strong>: M\u00dcKEMMEL bile\u015fik getiri f\u0131rsat\u0131<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p><strong>Genel Tavsiye<\/strong>: Biyoteknoloji volatilitesi nedeniyle dolar-maliyet ortalamas\u0131 stratejisi ile uzun vadeli b\u00fcy\u00fcme i\u00e7in ALIM.<\/p>\n<h2>\u26a0\ufe0f Yat\u0131r\u0131m Riskleri ve Olumlu Sinyaller<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Temel Riskler<\/h3>\n<ul>\n<li><strong>Klinik Deneme Ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong>: Bir biyoteknoloji \u015firketi olarak, ZLAB klinik deneme aksakl\u0131klar\u0131 riski ta\u015f\u0131r ve bu durum de\u011ferlemeyi \u00f6nemli \u00f6l\u00e7\u00fcde etkileyebilir. \u0130la\u00e7 geli\u015ftirme end\u00fcstrisinde ba\u015far\u0131s\u0131zl\u0131k oran\u0131 y\u00fcksektir.<\/li>\n<li><strong>D\u00fczenleyici Engeller<\/strong>: \u00c7in ve uluslararas\u0131 d\u00fczenleyici onaylar s\u00fcrekli zorluklar sunar. FDA veya NMPA gibi kurumlar\u0131n gecikmeleri veya reddi ticarile\u015ftirme takvimlerini aksatabilir.<\/li>\n<li><strong>Mali S\u00fcrd\u00fcr\u00fclebilirlik<\/strong>: K\u00e2rl\u0131l\u0131\u011fa do\u011fru ilerleme kaydedilse de, \u015firket h\u00e2l\u00e2 zarar etmektedir (-212,52 milyon $ TTM). Ar-Ge i\u00e7in devam eden sermaye gereksinimleri finansal bask\u0131 yaratabilir.<\/li>\n<li><strong>Rekabet Bask\u0131s\u0131<\/strong>: Onkoloji ve imm\u00fcnoloji alanlar\u0131 giderek rekabet\u00e7i hale gelmekte, b\u00fcy\u00fck ila\u00e7 \u015firketleri benzer tedaviler geli\u015ftirmektedir.<\/li>\n<li><strong>D\u00f6viz ve Jeopolitik Riskler<\/strong>: \u00c7in merkezli ve k\u00fcresel hedefleri olan ZLAB, d\u00f6viz dalgalanmalar\u0131 ve uluslararas\u0131 geni\u015flemeyi etkileyebilecek jeopolitik gerilimlerle kar\u015f\u0131 kar\u015f\u0131yad\u0131r.<\/li>\n<\/ul>\n<h3>2025 Yat\u0131r\u0131m\u0131 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>K\u00e2rl\u0131l\u0131\u011fa Giden Yol<\/strong>: \u015eirket, 2025 4. \u00e7eyrekte GAAP d\u0131\u015f\u0131 k\u00e2rl\u0131l\u0131\u011fa ula\u015fma yolunda olup, bu biyoteknoloji hisselerinde genellikle \u00f6nemli \u00e7arpan art\u0131\u015f\u0131n\u0131 tetikleyen kritik bir d\u00f6n\u00fcm noktas\u0131d\u0131r.<\/li>\n<li><strong>G\u00fc\u00e7l\u00fc Ticari Uygulama<\/strong>: VYVGART, ilk tam lansman y\u0131l\u0131nda 93,6 milyon $ gelir elde ederek sa\u011flam ticari yetenekler ve pazar kabul\u00fc g\u00f6sterdi.<\/li>\n<li><strong>\u00dcr\u00fcn Hatt\u0131 Tetikleyicileri<\/strong>: 2025 ikinci yar\u0131s\u0131nda ZL-1310 kay\u0131t denemesinin ba\u015flamas\u0131 ve bemarituzumab geli\u015fmeleri gibi bir\u00e7ok k\u0131sa vadeli tetikleyici \u00f6nemli yukar\u0131 potansiyel yarat\u0131yor.<\/li>\n<li><strong>Analist G\u00fcveni<\/strong>: 12 analistten 11&#8217;i al\u0131m tavsiyesi veriyor ve ortalama fiyat hedefi 56,31 $ ile %65+ yukar\u0131 potansiyel sunuyor.<\/li>\n<li><strong>Pazar Konumu<\/strong>: \u00c7in&#8217;in b\u00fcy\u00fcyen biyofarma pazar\u0131nda bask\u0131n konum ve k\u00fcresel geni\u015fleme yetenekleri \u00e7e\u015fitlendirilmi\u015f b\u00fcy\u00fcme f\u0131rsatlar\u0131 sa\u011fl\u0131yor.<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ul>\n<li><strong>Stratejik Birikim<\/strong>: K\u00fc\u00e7\u00fck pozisyon boyutlar\u0131yla ba\u015flay\u0131n ve giri\u015f zamanlamas\u0131 yerine dolar-maliyet ortalamas\u0131 ile maruziyeti kademeli olarak art\u0131r\u0131n.<\/li>\n<li><strong>Kazan\u00e7 Takvimi Fark\u0131ndal\u0131\u011f\u0131<\/strong>: 11 Kas\u0131m 2025 kazan\u00e7 a\u00e7\u0131klamas\u0131 i\u00e7in uyar\u0131lar kurun ve temel g\u00f6stergeler g\u00fc\u00e7l\u00fc kal\u0131rsa kazan\u00e7 sonras\u0131 zay\u0131fl\u0131klarda al\u0131m yapmay\u0131 d\u00fc\u015f\u00fcn\u00fcn.<\/li>\n<li><strong>Portf\u00f6y Da\u011f\u0131l\u0131m\u0131<\/strong>: Biyoteknoloji sekt\u00f6r\u00fc volatilitesi ve \u015firket \u00f6zel riskleri nedeniyle ZLAB maruziyetini toplam portf\u00f6y\u00fcn %5-10&#8217;u ile s\u0131n\u0131rlay\u0131n.<\/li>\n<li><strong>Uzun Vadeli Bak\u0131\u015f<\/strong>: Bu yat\u0131r\u0131m\u0131 k\u0131sa vadeli i\u015flem yerine 3-5 y\u0131ll\u0131k bir yat\u0131r\u0131m olarak g\u00f6r\u00fcn, b\u00f6ylece \u00fcr\u00fcn hatt\u0131 gelirle\u015ftirme potansiyelinin tamam\u0131n\u0131 yakalayabilirsiniz.<\/li>\n<li><strong>Esprili Ger\u00e7eklik Kontrol\u00fc<\/strong>: &#8220;Biyoteknoloji hisseleriyle i\u015flem yapmak, bilimsel deneyleri izlemek gibidir &#8211; %90 beklemek, %9 endi\u015felenmek ve %1 t\u00fcm \u00e7abaya de\u011fen muhte\u015fem sonu\u00e7lar!&#8221;<\/li>\n<\/ul>\n<h2>\u2705 Zai Lab Limited (ZLAB) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir Ticaret Platformu Se\u00e7in<\/td>\n<td>NASDAQ eri\u015fimi ve rekabet\u00e7i komisyon oranlar\u0131 sunan bir arac\u0131 kurum se\u00e7in<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap Fonlamas\u0131n\u0131 Tamamlay\u0131n<\/td>\n<td>Biyoteknoloji volatilitesini g\u00f6z \u00f6n\u00fcnde bulundurarak riske atmaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;ZLAB&#8221; Aramas\u0131 Yap\u0131n<\/td>\n<td>Do\u011fru menkul k\u0131ymeti ald\u0131\u011f\u0131n\u0131zdan emin olmak i\u00e7in tam sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td>\n<td>Piyasa emirleri yerine giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0130nceleyin ve Ger\u00e7ekle\u015ftirin<\/td>\n<td>Onaylamadan \u00f6nce miktar ve fiyat dahil olmak \u00fczere emir detaylar\u0131n\u0131 \u00e7ift kontrol edin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Profesyonel \u0130pucu<\/strong>: Arac\u0131n\u0131z sunuyorsa, tam olmayan paylar kullanmay\u0131 d\u00fc\u015f\u00fcn\u00fcn; b\u00f6ylece mevcut fiyatlarla tam hisse almak zorunda kalmadan pozisyonlar\u0131n\u0131z\u0131 kademeli olarak olu\u015fturabilirsiniz.<\/p>\n<h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Cazip?<\/h2>\n<p>Zai Lab Limited (ZLAB) hisse senedi ile yat\u0131r\u0131m yolculu\u011funa ba\u015flayanlar i\u00e7in Pocket Option, s\u00fcreci kolayla\u015ft\u0131ran birka\u00e7 avantaj sunar:<\/p>\n<ul>\n<li><strong>Eri\u015filebilirlik<\/strong>: Sadece 5 $ minimum depozito ile, \u00f6nemli sermaye taahh\u00fcd\u00fc olmadan pozisyon olu\u015fturmaya ba\u015flayabilirsiniz; ger\u00e7ek para ile stratejileri test etmek i\u00e7in m\u00fckemmeldir ancak risk s\u0131n\u0131rl\u0131d\u0131r.<\/li>\n<li><strong>H\u0131zl\u0131 \u0130\u015flem<\/strong>: Platformun 1 dakikal\u0131k KYC s\u00fcreci, tek bir kimlik belgesi kullanarak kay\u0131t sonras\u0131 hemen i\u015flem yapmaya ba\u015flaman\u0131z\u0131 sa\u011flar.<\/li>\n<li><strong>Esnek Para \u00c7ekme<\/strong>: Kripto paralar, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k se\u00e7enekleri dahil 100&#8217;den fazla para \u00e7ekme y\u00f6ntemi, uluslararas\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in kolayl\u0131k ve eri\u015filebilirlik sunar.<\/li>\n<li><strong>E\u011fitim Kaynaklar\u0131<\/strong>: <a href=\"https:\/\/pocketoption.com\/blog\">Pocket Option blogu<\/a>, yat\u0131r\u0131m kararlar\u0131n\u0131z\u0131 bilgilendirmek i\u00e7in de\u011ferli i\u00e7g\u00f6r\u00fcler ve piyasa analizleri sunar.<\/li>\n<\/ul>\n<h2>\ud83c\udf0d 2025&#8217;te Zai Lab: Biyoteknoloji \u0130novasyon Lideri<\/h2>\n<p>Zai Lab Limited, onkoloji, otoimm\u00fcn hastal\u0131klar, enfeksiyon hastal\u0131klar\u0131 ve sinirbilim alanlar\u0131nda yenilik\u00e7i tedaviler geli\u015ftirmeye ve ticarile\u015ftirmeye odaklanan \u00f6nde gelen bir biyofarmas\u00f6tik \u015firket olarak kendini kan\u0131tlad\u0131. \u015eirketin stratejik yakla\u015f\u0131m\u0131, dahili ila\u00e7 ke\u015ffi ile stratejik ortakl\u0131klar\u0131 birle\u015ftirerek \u00e7e\u015fitlendirilmi\u015f bir \u00fcr\u00fcn hatt\u0131 olu\u015fturuyor.<\/p>\n<p>\u015eirketin en geli\u015fmi\u015f varl\u0131\u011f\u0131 olan ZL-1310, DLL3 hedefli antikor-ila\u00e7 konjugat\u0131 olarak k\u00fc\u00e7\u00fck h\u00fccreli akci\u011fer kanseri tedavisinde potansiyel bir at\u0131l\u0131m\u0131 temsil ediyor. 2025 sonlar\u0131nda planlanan kay\u0131t denemesi ve 2027&#8217;ye kadar olas\u0131 h\u0131zland\u0131r\u0131lm\u0131\u015f onay ile bu program, bu zorlu kanser t\u00fcr\u00fc i\u00e7in tedavi manzaras\u0131n\u0131 d\u00f6n\u00fc\u015ft\u00fcrebilir.<\/p>\n<p><strong>2025 \u0130\u00e7in \u0130lgin\u00e7 Bir Ger\u00e7ek<\/strong>: Zai Lab, bu y\u0131l ara\u015ft\u0131rma ekibinin onkoloji i\u00e7in geli\u015ftirilen bir bile\u015fi\u011fin nadir n\u00f6rolojik hastal\u0131klar\u0131n tedavisinde beklenmedik etkinlik g\u00f6sterdi\u011fini ke\u015ffetmesiyle man\u015fetlere \u00e7\u0131kt\u0131; bu, tamamen yeni bir terap\u00f6tik uygulamaya yol a\u00e7t\u0131 ve ila\u00e7 ke\u015ffinin tesad\u00fcfi do\u011fas\u0131n\u0131 g\u00f6sterdi!<\/p>\n"},"faq":[{"question":"Zai Lab Limited (ZLAB) hisseleri nereden al\u0131nabilir?","answer":"ZLAB hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"Zai Lab Limited hisselerine yat\u0131r\u0131m yaparken nelere dikkat etmeliyim?","answer":"Klinik deneme sonu\u00e7lar\u0131, d\u00fczenleyici onaylar, finansal performans ve piyasa ko\u015fullar\u0131 gibi fakt\u00f6rleri takip etmek \u00f6nemlidir. Ayr\u0131ca, biyoteknoloji sekt\u00f6r\u00fcndeki volatiliteyi g\u00f6z \u00f6n\u00fcnde bulundurarak risk y\u00f6netimi yapmal\u0131s\u0131n\u0131z."},{"question":"Zai Lab Limited hisseleri i\u00e7in 2025 sonras\u0131 fiyat beklentileri nelerdir?","answer":"Analist projeksiyonlar\u0131na g\u00f6re 2025 sonunda 34-36 $ aral\u0131\u011f\u0131nda, 2026'da 48-52 $ aral\u0131\u011f\u0131nda ve 2030'a kadar 65-75 $ aral\u0131\u011f\u0131nda fiyatlar beklenmektedir."},{"question":"Yeni ba\u015flayan biri Zai Lab hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"K\u00fc\u00e7\u00fck pozisyonlarla ba\u015flay\u0131p dolar-maliyet ortalamas\u0131 stratejisi uygulamak, kazan\u00e7 takvimine dikkat etmek ve portf\u00f6yde %5-10 aras\u0131 maruziyetle riskleri s\u0131n\u0131rlamak \u00f6nerilir."},{"question":"Pocket Option platformu Zai Lab hisseleri i\u00e7in neden tercih edilebilir?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 KYC s\u00fcreci, \u00e7oklu para \u00e7ekme y\u00f6ntemleri ve e\u011fitim kaynaklar\u0131 ile yeni yat\u0131r\u0131mc\u0131lar i\u00e7in eri\u015filebilir ve kullan\u0131c\u0131 dostu bir platformdur."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Zai Lab Limited (ZLAB) hisseleri nereden al\u0131nabilir?","answer":"ZLAB hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"Zai Lab Limited hisselerine yat\u0131r\u0131m yaparken nelere dikkat etmeliyim?","answer":"Klinik deneme sonu\u00e7lar\u0131, d\u00fczenleyici onaylar, finansal performans ve piyasa ko\u015fullar\u0131 gibi fakt\u00f6rleri takip etmek \u00f6nemlidir. Ayr\u0131ca, biyoteknoloji sekt\u00f6r\u00fcndeki volatiliteyi g\u00f6z \u00f6n\u00fcnde bulundurarak risk y\u00f6netimi yapmal\u0131s\u0131n\u0131z."},{"question":"Zai Lab Limited hisseleri i\u00e7in 2025 sonras\u0131 fiyat beklentileri nelerdir?","answer":"Analist projeksiyonlar\u0131na g\u00f6re 2025 sonunda 34-36 $ aral\u0131\u011f\u0131nda, 2026'da 48-52 $ aral\u0131\u011f\u0131nda ve 2030'a kadar 65-75 $ aral\u0131\u011f\u0131nda fiyatlar beklenmektedir."},{"question":"Yeni ba\u015flayan biri Zai Lab hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"K\u00fc\u00e7\u00fck pozisyonlarla ba\u015flay\u0131p dolar-maliyet ortalamas\u0131 stratejisi uygulamak, kazan\u00e7 takvimine dikkat etmek ve portf\u00f6yde %5-10 aras\u0131 maruziyetle riskleri s\u0131n\u0131rlamak \u00f6nerilir."},{"question":"Pocket Option platformu Zai Lab hisseleri i\u00e7in neden tercih edilebilir?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 KYC s\u00fcreci, \u00e7oklu para \u00e7ekme y\u00f6ntemleri ve e\u011fitim kaynaklar\u0131 ile yeni yat\u0131r\u0131mc\u0131lar i\u00e7in eri\u015filebilir ve kullan\u0131c\u0131 dostu bir platformdur."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Zai Lab Limited (ZLAB) Hisseleri Nas\u0131l Al\u0131n\u0131r - Zai Lab Limited (ZLAB) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-zai-lab-limited\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Zai Lab Limited (ZLAB) Hisseleri Nas\u0131l Al\u0131n\u0131r - Zai Lab Limited (ZLAB) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-zai-lab-limited\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-31T09:52:43+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-zai-lab-limited\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-zai-lab-limited\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Zai Lab Limited (ZLAB) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Zai Lab Limited (ZLAB) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-31T09:52:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-zai-lab-limited\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-zai-lab-limited\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-zai-lab-limited\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-zai-lab-limited\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-zai-lab-limited\/\",\"name\":\"Zai Lab Limited (ZLAB) Hisseleri Nas\u0131l Al\u0131n\u0131r - Zai Lab Limited (ZLAB) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-zai-lab-limited\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-zai-lab-limited\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"datePublished\":\"2025-08-31T09:52:43+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-zai-lab-limited\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-zai-lab-limited\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-zai-lab-limited\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-zai-lab-limited\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Zai Lab Limited (ZLAB) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Zai Lab Limited (ZLAB) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Zai Lab Limited (ZLAB) Hisseleri Nas\u0131l Al\u0131n\u0131r - Zai Lab Limited (ZLAB) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-zai-lab-limited\/","og_locale":"tr_TR","og_type":"article","og_title":"Zai Lab Limited (ZLAB) Hisseleri Nas\u0131l Al\u0131n\u0131r - Zai Lab Limited (ZLAB) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-zai-lab-limited\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-31T09:52:43+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-zai-lab-limited\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-zai-lab-limited\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Zai Lab Limited (ZLAB) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Zai Lab Limited (ZLAB) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-31T09:52:43+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-zai-lab-limited\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-zai-lab-limited\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-zai-lab-limited\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-zai-lab-limited\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-zai-lab-limited\/","name":"Zai Lab Limited (ZLAB) Hisseleri Nas\u0131l Al\u0131n\u0131r - Zai Lab Limited (ZLAB) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-zai-lab-limited\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-zai-lab-limited\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","datePublished":"2025-08-31T09:52:43+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-zai-lab-limited\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-zai-lab-limited\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-zai-lab-limited\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-zai-lab-limited\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Zai Lab Limited (ZLAB) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Zai Lab Limited (ZLAB) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":363261,"slug":"how-to-buy-zai-lab-limited","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Zai Lab Limited (ZLAB) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Zai Lab Limited (ZLAB)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-zai-lab-limited\/"},"pt_AA":{"locale":"pt_AA","id":363262,"slug":"how-to-buy-zai-lab-limited","post_title":"Como comprar a\u00e7\u00f5es da Zai Lab Limited (ZLAB) - Investimento em a\u00e7\u00f5es da Zai Lab Limited (ZLAB)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-zai-lab-limited\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/363260","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=363260"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/363260\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334018"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=363260"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=363260"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=363260"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}